chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness, tingling in face, neck, back of legs, back of arms, scalp, feet and back. Started a few days after vaccine. Mostly gone now just a bit of random numbness. I was very afraid and still afraid it will get worse.  My son still has numbness in arm and leg on left side. Brought him to emergency room day after vaccine. They couldn't help him so when mine started a few days later I went to natural doctor for treatment
pt recv vax & exp redness, swelling, warmth @ site of inj;red right deltoid area;ice packs no fever T98.6;
This spontaneous report was received from a Medical Assistant refers to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On multiple unspecified dates, the patients were vaccinated with doses of improperly stored GARDASIL 9 lot # K026246, expiry date 28-JAN-2017, 0.5 specific dose (frequency unspecified), in the arm (deltoid). No adverse effects were reported. No product quality complaint (PQC) was involved. No further information provided. This is one of two reports received from the same reporter. Additional information has been requested.
Chills and fever. It was only 99.8 and then later in the day it did go to 100.3 and nausea. Weakness.
I suffered petechiae bruising on my thighs after all 3 doses of the Moderna vaccine. At first, I didn't know that's what caused the bruising - I was referred to a hematologist who did a number of tests and determined a causal link. I got petechial bruising a few weeks after each of all 3 doses I received - and then I had petechiael bruising 8 months post booster, as well as spontaneous non-petechial bruising
Sinus drainage with cough; Sinus drainage with cough; fatigue; Terrible Laryngitis; post nasal drip; minimal raspy voice/Mild hoarseness; This is a spontaneous report from a contactable Nurse reporting for herself.    A 65-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Deltoid Left on 25Feb2021 13:00 (Batch/Lot Number: EN6203) as single dose for covid-19 immunisation  .  Medical history included diabetes mellitus from 2017 (Diabetes diagnosed 4 years ago) , obesity (Obesity has been 10 years or more) , hypersensitivity (Allergies for lifetime) , arthritis  (Arthritis diagnosed 20 some years ago) , hypertension from 2011 (High blood pressure diagnosed 10 years ago) , depression  (Depression diagnosed 30 years ago) , breast cancer female from 2019  , breast conserving surgery. Concomitant medication included anastrozole (ANASTROZOLE) taken for breast cancer.  The patient experienced terrible laryngitis on 28Feb2021 with outcome of not recovered , fatigue  on 01Mar2021 with outcome of recovering , sinus drainage with cough on 04Mar2021 09:00 with outcome of not recovered , post nasal drip  on 2021 with outcome of unknown , minimal raspy voice/mild hoarseness. All the reported events were considered Important Medical Events.  Course of the events: the patient received the vaccine on 25Feb2021, and 3-4 days after, she started getting terrible Laryngitis. It is a little better. She also was fatigued. She did not run a fever. She did develop a little sinus drainage and cough within the last 4 days. She can smell and taste. She called her doctor and he said it is a side effect or reaction to the COVID vaccine. She wanted to know if that was likely or if there had been reports of any others having this reaction. He told her not to get second vaccine. The patient  was difficult to understand due to minimal raspy voice.  Follow up information has been requested; Sender's Comments: Based on temporal association, a contributory role of bnt162b2 to the reported  events cannot be totally excluded.  Case will be reassessed if additional information is  received.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a physician concerning a 29 year old female patient who in February 1999 was vaccinated with one dose of varicella. Concomitant therapy included birth control pills. On 23-FEB-1999 the patient experienced approximately 25 to 30 erythematous papules throughout her body. She had no fever and the papules did not vesiculate or crust, and there was no necrosis. The patient sought unspecified medical attention. PCR analysis results are pending. A skin biopsy was also performed with results pending. No further information is available.
Persistent pain and limitation of range of movement (now for more than  10 weeks) in left shoulder on raising arm since receiving vaccination. Ibuprofen 400 mg three times a day 25 mg Benadryl at night for sleep. Consulted with Dr. on October 13, 2020 and November 6, 2020. Referred to Orthopedic Surgeon on November 10 and November 17. Had x-rays of shoulder on November 10 and MRI of shoulder on November 12.  Received corticosteroid injection in left shoulder by Dr. on November 17.
I called My primary care doctor on  Thursday  afternoon the 14th to see what they thought. They said I should go to ER. I called my Psychiatrist and his Nurse said call my regular primary care doctor. Since then I?ve been icing my back, knees, ankles and shoulders.. I?ve been taking ibuprofen and  acetaminophen- Alternately . Resting but the pain only subsided for a few minutes
Dull aching pain in both shoulders with all the muscles in both upper arms, more pain in Rt deltoid and biceps muscles. Dull aching pain in neck muscles and lower body.
high temp 103.5 degree F X 48 degree +  MOTRIN/TYLENOL
Case number PHEH2015US019748, is an initial spontaneous report received from a pharmacist on 05 Oct 2015. This report refers to a 31 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: not reported) on an unknown date, which was stored at 70 degree Fahrenheit for 1 hour. No adverse event was reported following this administration error.
Flushing on face and upper chest with no other symptoms ie itching, swelling, tachycardia, SOB, VS normal. Started approx 10 mins after injection lasted approx 3 hours.  Injection given at 10 am.
This spontaneous report was received from a nurse practitioner, via field representative and refers to a 20-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL 9 (dose, route and site of administration, lot # and expiration date were not reported). On an unknown date in September 2018 (reported as 2-3 weeks ago), the patient was vaccinated with second dose of GARDASIL 9 (dose, route and site of administration, lot # and expiration date were not reported). On an unknown date in 2018, following vaccine administration, the patient experienced shoulder pain and she was unable to lift her arm. On an unknown date, she was seen by the nurse practitioner and the nurse believed that the patient had shoulder injury related to vaccine administration (SIRVA). The nurse practitioner referred the patient to see an orthopedist on an unspecified date. The patient's symptoms did not resolve at the reporting time. Therapy with GARDASIL 9 was discontinued. The reporter considered the event to be related to GARDASIL 9.
Tachycardia, chest pain, neck pain, pressure in head, chest and neck, legs and arms numb and tingly, dizziness, blurred vision, shortness of breath - 03/05/2021 started at 7:30pm Stuffed nose, cold chills and shivers, body aches, shortness of breath, chest pain, neck pain, pressure in chest, neck, and head, large red, hot, swollen, itchy spot around injection site on left arm, resting heart rate of 95-110 all day (normal resting around 75)  - 03/06/2021 all day  Red spot on left arm hot and itchy - 03/07/2021 - current   Heart rate has remained high since  03/05/2021
This case was reported by a consumer via call center representative and described the occurrence of chest burning in a 69-year-old female patient who received SHINGRIX for prophylaxis. On 14th August 2018, the patient received the 1st dose of SHINGRIX. In August 2018, 2 days 11 hrs after receiving SHINGRIX, the patient experienced chest burning, facial flushing and tingling skin. On 15th August 2018, the patient experienced pain in arm. On 16th August 2018, the patient experienced insomnia and sweating. On 17th August 2018, the patient experienced feeling of warmth facial. The patient was treated with ADVIL. On an unknown date, the outcome of the chest burning was recovering/resolving and the outcome of the facial flushing, tingling skin, feeling of warmth facial, pain in arm, insomnia and sweating were unknown. It was unknown if the reporter considered the chest burning, facial flushing, tingling skin, feeling of warmth facial, pain in arm, insomnia and sweating to be related to SHINGRIX. Additional details were provided as follows: The patient wanted to remain anonymous. At 11:00, the patient received SHINGRIX in left arm. The patient did not experience any events the day she received the vaccine. The next day she had an achy arm. Last night (16th August 2018) at approximately 10:00 pm, she felt a burning sensation in her chest and her face was flushed and tingling. She drank cold water and it resolved in 10 to 15 minutes. She woke up at 2:30 am in the morning of reporting date with the same burning event and she was also sweating all over (latency 2 days). She took ADVIL and drank cold water and it resolved within 10 to 15 minutes. Two days after vaccination, she experienced insomnia because the events interrupted her normal sleep pattern. In the morning of reporting date, three days after receiving SHINGRIX, she felt fine except for her face felt a little warm. In August 2018, achy arm was resolved. This case has been linked with US2018149807, reported by same reporter for patient's husband.
Feeling cold; It is making her very thirsty; Tingling all over; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), in 2022 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING COLD (non-serious) with onset 2022, outcome "unknown"; THIRST (non-serious) with onset 2022, outcome "unknown", described as "It is making her very thirsty"; PARAESTHESIA (non-serious) with onset 2022, outcome "unknown", described as "Tingling all over". Additional information: reporter stated that they just gave the patient the Pfizer COVID-19 vaccine and it has been about 10 minutes, she said that she was feeling cold and tingling all over. They gave her water because she said it was making her very thirsty. She said the last time she ate was last night. Reporter was not sure what was the last time she has eaten.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Two days post vax, the pt stated her left hand felt scalded. The joints of both hands, then feet, shoulders and knees were painful and swollen. She was seen by a physician who prescribed anti-inflammatories, then Vioxx, and doxycycline for one month.
Woke up at 230 am  ten hours after receiving 2nd dose with fever, chills feeling awful,  unable to warm up. That lasted approximately fours hours. Three days later tinnitus began all day and night lasting two and a half weeks sounding like some kind of Morris code.  It slowly began  to fade. I have never had tinnitus!
Client was vaccinated with Pfizer vaccines on approximate dates of  2/15 and 3/15/2021 at Bergen Pines Hospital Public Clinic in Paramus NJ.  Tested asymptomatic Covid on 8/17/2021.  Reported as case of breakthrough Covid illness.  Client had contact with positive person several days before she tested positive.
Swelling and soreness developed 2-3 days after vaccination intense redness, "heat" and increased swelling began 3rd days thereafter. (see photo attached)
Information has been received from a nurse referring to a 7 years old male patient. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 26-SEP-2017, the patient accidentally vaccinated the ZOSTAVAX (0.65 ml, once, route, lot# and expiration date were unknown) for prophylaxis instead of varicella virus vaccine live (Oka/Merck) (manufacturer unknown) (Wrong drug administered). No adverse events were noted in the patient. It was unknown if there was relevant lab work.
Patient presents to clinic 1/24/08 with active lesions on his abdomen. Zostavax inj was given to patient on 1/10/08. Zostavax was ordered for this patient who is on an immunosuppressant, Etanercept to treat his rheumatoid arthritis. Valacyclovir 1000mg TID x 7 days was ordered by provider in clinic to treat active herpes zoster.
This case was reported by a healthcare professional, via a sales representative, and described the occurrence of seizure like activity in a 14-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). Concurrent vaccination included HPV vaccine (non-GSK); Merck; unknown; unknown given on 13 August 2013; meningococcal acwy vaccine (non-GSK); non-GSK manufacturer; unknown; unknown given on 13 August 2013. On 13 August 2013 the subject received unspecified dose of HAVRIX (.5 ml, unknown). On 13 August 2013, less than one day after vaccination with HAVRIX, the subject experienced seizure like activity. The healthcare professional reported the subject experienced seizure like activity (unknown symptoms) sometime after the injection in the office. The patient had "Mountain Dew and crackers, felt better, and the seizure activity resolved". This case was assessed as medically serious by GSK. On 13 August 2013, the event was resolved.
Internal tremors lasting about 10 minutes that come and go without fever, weakness, nausea.  The internal tremors are the most severe symptom.
EXTREME REACTION TO THE FIRST SHINGREX SHOT(50MCG IN.J(Mm)SNGDOSE VL 10Pk Weakness, body aches, fever (under 101) nausea, neuropathy in both feet and both hands, swollen and red at cite of injection. Five days after the injection, swelling at the injection site was reduce but a new area (3 " x 3") below the original swelling, became, hot and swollen and itched. This new area of swelling began to shrink in about 36 hours. I was seen by a doctor. He had no explanation for the second swelling and pain in the arm.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Oct2022 as dose 4 (booster), single (Lot number: 050D22A) at the age of 50 years for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Allergy" (unspecified if ongoing), notes: Known allergies: Yes; "ADPKD" (unspecified if ongoing); "hashimoto's" (unspecified if ongoing); "RA" (unspecified if ongoing); "CVA" (unspecified if ongoing); "CKD2" (unspecified if ongoing); "cerebral aneurysms" (unspecified if ongoing); "adrenal insufficiency" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing). The patient took concomitant medications (immunosuppressants). The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 25Sep2023, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (25Sep2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid started on 25Sep2023.
Symptoms- pale, disphoretic Pt given water and was assissted by two staff members to medical tent. Pt placed in supine psotion with legs elevated. vital signs obtained x2. Pt released by med provider. 30 min observation in good condition
Patient Hospitalized;  COVID-19 positive 8.24.21.  Admitted for COVID pneumonia.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory insufficiency COVID-19 Pneumonia due to COVID-19 virus   HOSPITAL COURSE: Patient is a 81 y.o. female who presented with COVID pneumonia.  Doing much better at this time.  Continued remdesivir and Decadron.  Continued supplemental oxygen. Patient finished 3 days total of remdesivir and 3 days of IV Decadron.  She has weaned down to 2 L and states she is feeling much better.  States her breathing is ?normal for her? at this time.  Discharge home on her normal 2 L of oxygen.  Will finish an additional 7 days of orally Decadron as an outpatient.  Advised her to follow-up in 1-2 weeks with her primary care physician. Active Issues Requiring Follow-up Acute hypoxemic respiratory failure Assessment & Plan Continue on 5 L of oxygen at this time.   August 25th:  Much improved at this time.  On 3 liters oxygen   COPD (chronic obstructive pulmonary disease) with chronic bronchitis Assessment & Plan Continue on room meter dose inhaler for chronic obstructive pulmonary disease.   August 20th:  Patient on 3 liters today.  Continue pulmonary regimen.   * Pneumonia due to COVID-19 virus Assessment & Plan Patient placed on COVID protocol at this time.  Started on remdesivir at this time.  Started on IV Decadron at this time.  Continue oxygen.  She normally is on 2 L of oxygen.  Currently on 5 L at this time.  Continue to watch closely.   August 25th:  Continue remdesivir and IV Decadron at this time.   August 26th:  Finish 3 days of remdesivir and 3 days of IV Decadron.  Patient is on her baseline 2 L of oxygen at this time.  Placed on orally Decadron 6 mg orally q.day for an additional 7 days.  Discharge home at this time.
This spontaneous report was received from a 72 year old male consumer referring on himself. Patient's medical history included penicillin allergy. On 26-DEC-2014 the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported), intramuscular. Concomitant therapies included DIOVAN. The patient called in to ask about pain he is having at the site of injection of the ZOSTAVAX vaccine which was administered intramuscular. The patient stated that he has been experiencing pain that is running from the left elbow that radiates toward the torso. He stated that this pain has not gone away since the administration of the vaccine on 26-DEC-2014. Patient didn't sought medical attention. The outcome of pain that is running form the left elbow that radiates toward the torso and pain he is having at the site of injection of ZOSTAVAX vaccine which was administered intramuscular was reported as not recovered/not resolved. Additional information is not expected.
Woke up the day after booster vaccination with right sided weakness.  Overall suspect more likely due to underlying previously undiagnosed HTN, DM, hyperlipidemia but occurred the day following booster vaccination.
Information has been received from a healthcare worker concerning a 22 year old female who was vaccinated with three doses of Gardasil. The first dose on 20-MAR-2007 (lot #655503/0012U), the second dose on 30-MAY-2007 (lot #657736/0389U) and the third dose on 19-SEP-2007 (lot #658563/1063U). There was no concomitant medication. on 19-SEP-2007 the patient experienced 1.5 cm "knot" in her left deltoid at the injection site and pain at the injection site. The injection site is extremely tender to touch, with some redness and slightly blue in color. The patient is having problems sleeping because of the pain. The first and third doses were administered in her left deltoid and the second dose was administered in her right deltoid. On 15-OCT-2007 an ultrasound of the injection site area was performed which showed a solid mass. It was reported that the patient's events were considered to be disabling. No further information is available. Additional information has been requested.
Lip, tongue, and throat swelling. Some chest tightness. She did take 1/2 tablet Benadryl that night and was given prescription for prednisone the next day when I saw her in clinic.
The patient was seen in the office on 02/08/2023 and received her 4th Hib vaccine, however it was not required since the patient had already received her third dose after the age of 12 months (on 7/28/2022). Therefore, the patient received an extra dose of Hib.
Bad after taste; Covid-19; Diarrhea; This spontaneous case was reported by a patient and describes the occurrence of DYSGEUSIA (Bad after taste), COVID-19 (Covid-19) and DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for an unknown indication.    No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. and NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Bad after taste), COVID-19 (Covid-19) and DIARRHOEA (Diarrhea). At the time of the report, DYSGEUSIA (Bad after taste), COVID-19 (Covid-19) and DIARRHOEA (Diarrhea) outcome was unknown.            No concomitant medications were reported.  Patient still contracts the virus after being vaccinated. Patient had Moderna since patient started in May of last year so, patient had four doses. Patient had to wait 90 days after she get down with this COVID before getting third booster.  No treatment medications were reported.
1 day after Flumist, headache, pale, warm to touch, 2nd day rash on forehead and right side of forehead, seen in office (12/10/04) at pediatricians. Observe.
5/9/01 at 10:50 AM, phone call from mother, face is red (looks like a rash) swelling under one eye. No pain on fever. Will give Benadryl. On 5/11/01, I called mother and still face is red, no swelling pain. Had low fever last night and the night before. Gave Motrin and giving Benadryl every 4 hours and since 5/7/01. Child active with no complaints. On 5/15/01, child with non redness and doing well.
Hospitalization: 2/22/2023 - 3/4/2023 (10 days) Presentation to the ED: abd pain COVID + date: 3/2/2023 Treatment: Zosyn Discharge to: home.  EP7534 3/19/2021 ER8735 4/9/2021 FE3594 12/14/2021
Information has been received from a nurse concerning two teenage females who on an unspecified date were vaccinated with their second dose of VARIVAX (Merck) (lot#667820/0757Z). On an unspecified date the patients had redness, pruritus and local site reactions. The patients sought medical attention and were treated with ice pack and comfort measures. On an unspecified, the patients recovered. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports received from the same source. Additional information has been requested.